GEFCO Group, a global provider of industrial supply chain services has been awarded a Good Distribution Practice (GDP) compliance certificate for the road transportation process of pharma products.
The external auditor – Bureau Veritas – analysed the GEFCO quality system and the ability to answer customer requirements in Czech Republic, Slovakia, Hungary, Greece, Romania and the Group’s headquarters in France. In 2019, GEFCO said it will extend the deployment of the GDP certification for road activities in additional European countries.
The GDP certificate, valid for three years, shows that the company fulfils the requirements of the European Commission Guidelines on Good Distribution Practice of Pharmaceutical Products for human use. The company said it reflects GEFCO’s commitment to high quality as well as its understanding of clients’ challenges, including traceability of the goods, thus preventing risks of counterfeit or falsification
The Life Sciences and Healthcare logistics market is changing and becoming more complex, GEFCO noted. “With the volume increase in temperature-sensitive products, as well as the regulations related to their transportation, companies need to put more focus on control and security. Failure to do so might represents a risk to put in danger public health and a risk to lose high-value cargo,” it said.
As a specialist in Life Sciences and Healthcare logistics, GEFCO offers door-to-door, temperature-controlled, integrated logistics, multimodal and fully compliant solutions.
“GEFCO has a strong history in the Life Science and Healthcare sector and is fully aware of its client’s stakes,” said Alain Vignon, head of GEFCO Management System. “The GDP compliance is further proof of GEFCO’s commitment to supplying secure and compliant Life Sciences and Healthcare shipments and ensuring the integrity of products.”
Earlier this year, GEFCO opened its third Life Sciences and Healthcare dedicated temperature-controlled warehouse, located near London Heathrow airport, UK, which complements GEFCO Air & Sea warehouses’ in Frankfurt, Germany and Amsterdam, Netherlands.
Last year, the Group has been awarded the IATA-CEIV Pharma Certification for its Air & Sea activity in Netherlands.